eralized, symmetrical overgrowth syndromes in this review.
There have been several suggestions regarding the definition of generalized overgrowth. Perhaps the most sensible suggestion came from Cohen [1998] who recommended that classification remain "loose," simply serving as an organizing principle for review and discussion. Operationally, this accommodates the considerable phenotypic and etiologic heterogeneity in this domain. For example, approximately 10% of the children with Sotos syndrome have a height <97th centile .
More formal definitions have been proposed, however, and more recent definitions suggest overgrowth should be considered if there are dysmorphic features and a height and head circumference greater +2 SD, the target height (calculated on the basis of mid-parental height) is greater +2 SD, or if a patient has the typical dysmorphic features of a known "overgrowth syndrome" [Visser et al., 2009; Neylon et al., 2012] . Verge and Mowat [2010] provided a similar definition but also suggested overgrowth should be considered if birth weight was >4.5 kg [Verge and Mowat, 2010] .
The overgrowth syndromes presented all have intellectual disability as a key feature, although it is possible that borderline or low-normal intellect could be seen. It is important to note that some causes of overgrowth, macrosomia, tall stature, macrocephaly, or obesity are not seen in the context of syndromes. When intellect is normal, the most common causes of overgrowth are: (1) familial, (2) growth acceleration driven by over-nutrition (includes infants of diabetic mothers), (3) en docrine conditions (such as precocious puberty, hyper thyroidism, congenital adrenal hyperplasia, growth hormone-secreting adenoma, familial glucocorticoid deficiency, and aromatase deficiency) [Verge and Mowat, 2010] .
The overgrowth syndromes are important to diagnose, not just for accurate genetic counseling, but also for knowledge surrounding cancer surveillance and prognosis.
Procedure
An OMIM search of abstracts with the word "overgrowth" returned 192 entries, and a search for "macrosomia" returned 41 entries. We also searched PubMed using the search terms "overgrowth" and "macrosomia" to identify conditions. Previous review articles on overgrowth, obesity, macrocephaly, and tall stature were also examined to ensure no syndromes were missed [Cohen, 1998; Sotos and Argente, 2008; Williams et al., 2008; Verge and Mowat, 2010; Sabin et al., 2011; Argente and Sotos, 2012; Neylon et al., 2012; Durand and Rappold, 2013; Tatton-Brown and Weksberg, 2013] . From this, we classified each disorder as either: (1) a generalized overgrowth condition, (2) a segmental overgrowth condition, (3) a condition associated with fetal and neonatal macrosomia but not usually overgrowth in childhood and later life, (4) a condition mostly associated with tall stature, (5) a condition mostly associated with macrocephaly, or (6) a condition mostly associated with obesity. We used this classification system to identify core overgrowth conditions as well as to report on differential diagnoses or conditions that mimic overgrowth. 
Results
Based on a literature review, syndromes commonly associated with generalized overgrowth are covered in the discussion below and are also listed in online supplementary Table 1 (for all online suppl. Tables, see www. karger.com/doi/10.1159/000484532 ). To cover diagnoses made by chromosomal microarray, chromosomal conditions often associated with overgrowth are listed in Table 1 . Regarding differential diagnoses to outline conditions that are not overgrowth syndromes by strict definition, Table 2 presents syndromes associated with macrosomia at birth that later usually progress to normal growth parameters or failure to thrive. Online supplementary Table 2 lists syndromes associated with segmental overgrowth. Online supplementary Table 3 lists condi- Scurr et al., 2011; van Bon et al., 2012] Costello (and other RASopathies)
HRAS AD Initial polyhydramnios, edema, and macrosomia are followed by failure to thrive, growth deficiency, macrocephaly, and developmental delay Craniofacial: coarse face, low set ears, thick lobes, downslanting palpebral fissures, thick lips, macroglossia, full cheeks, short bulbous nose Skin: cutis laxa, curly hair, teeth abnormalities Perioral, nasal and anal papillomas, deep palmar and plantar creases Cardiac: pulmonary stenosis and other congenital heart disease [Gripp and Lin, 2017] Elejalde (Acrocephalopolydactylous dysplasia) unknown AR Lethal multiple congenital abnormality disorder with increased birth weight, globular body with thick skin, organomegaly, and fibrosis in multiple tissues [Phadke et al., 2011] Familial hyperinsulinism
usually AR, sometimes AD
Severe hypoglycemia at birth often associated with macrosomia [Kapoor et al., 2013; Glaser, 2017] Infant of diabetic mother or maternal overweight --In addition to macrosomia, infants of diabetic mothers have a 2-to 3-fold increase in congenital abnormalities (6 -9%) including: neural tube defects, congenital heart disease, renal and skeletal anomalies [Ornoy, 2011] tions that can mimic overgrowth but would usually only show a significant increase in only 1 of the 3 parameters (height, weight, and head circumference). Many overgrowth, macrocephaly, and obesity syndromes have an association with neoplasia because of widespread alterations in gene expression and cell-signaling pathways; the associated tumor risk of some of these syndromes is presented in Table 3 .
The syndromes listed below represent the currently known monogenic forms of overgrowth. We present the syndromes in order of expected frequency of presentation to a clinical genetics unit, although accurate data on prevalence and proportion coming to medical attention are not available for most conditions.
Beckwith-Wiedemann Syndrome
Suggested clinical diagnostic criteria require the presence of at least 2 major and 1 minor criteria. However, with advances in molecular testing, it is now recognized that subtle phenotypes are possible, so Beckwith-Wiedemann syndrome (BWS; OMIM 130650) should be considered if there is one or more of the following major features: macrosomia, hemihyperplasia, macroglossia, visceromegaly, ear creases/pits, infraorbital creases, embryonal tumors, omphalocele, neonatal hypoglycemia, renal abnormalities, cytomegaly of the fetal adrenal cortex, cleft palate (rare), and cardiomegaly or structural cardiac anomalies. Minor findings include polyhydramnios during pregnancy, nevus simplex, diastasis recti, and advanced bone age. Facial features can be subtle and include infraorbital creases and midface retrusion. Linear growth slows around the age of 8 years, and the facial and physical features become less obvious with age. BWS methylation studies involve techniques such as methylation sensitive MLPA which examines DNA methylation and copy number within subregions of 11p15.5. This detects methylation abnormalities such as: (1) loss of methylation of the imprinting center 2 on the maternal chromosome, (2) gain of methylation of imprinting center 1 on the maternal chromosome, and (3) paternal uniparental disomy of 11p15.5. In addition, Sanger or next generation sequencing methods are needed to detect CDKN1C mutations that are present in only 5% of sporadic BWS cases but in 40% of patients with a family history of BWS Greer et al., 2008; Choufani et al., 2010] .
Sotos Syndrome
Sotos syndrome (OMIM 117550) is characterized by pre-and postnatal overgrowth with intellectual disability that is usually mild to moderate, but can be severe. The characteristic facial gestalt includes prominent forehead, downslanting palpebral fissures, and malar flushing. At birth, the mandible appears small, but by childhood it is pointed, and in adulthood, often prominent and square. Patients often have advanced bone age, congenital heart disease (20%), ventriculomegaly or other central nervous system abnormalities identified at MRI, renal abnormalities (15%), scoliosis (30%), seizures (25%), and tumors (3%). Heterozygous mutations of NSD1 are responsible, and it is estimated that a mutation will be detected in over 90% of the patients (5-10% are larger deletions detected by MLPA or cytogenetic studies) following accurate phenotyping Rahman, 2004, 2007; Cecconi et al., 2005; Douglas et al., 2005; Tatton-Brown et al., 2005; Fickie et al., 2011; Hirai et al., 2011] .
Simpson-Golabi-Behmel Syndrome
Pre-and postnatal overgrowth is present often with polyhydramnios in pregnancy ( ∼ 95%). Craniofacial features of Simpson-Golabi-Behmel syndrome (SGB; OMIM 312870) include macrocephaly ( ∼ 75%), coarse facial features and square face ( ∼ 90%), downslanting palpebral fissures, hypertelorism ( ∼ 50%), epicanthic folds, short nose/broad nasal bridge ( ∼ 80%), ear lobe creases ( ∼ 70%), macrostomia ( ∼ 85%), macroglossia, midline groove in lower lip/deep midline groove in the tongue ( ∼ 50%). Skeletal findings include postaxial polydactyly ( ∼ 20%), syndactyly ( ∼ 20%), brachydactyly ( ∼ 50%), nail hypoplasia ( ∼ 25%), broad/short hands ( ∼ 80%), and vertebral defects ( ∼ 30%). Other findings can include thin muscular body habitus, organomegaly, supernumerary nipples ( ∼ 50%), congenital heart disease ( ∼ 35%), cardiac conduction defects ( ∼ 15%), cryptorchidism, herniae, diaphragmatic hernia ( ∼ 30%), and cleft lip or palate ( ∼ 25%). Intellectual disability can be mild to severe. The condition is X-linked involving mutations in GPC3 [Neri et al., 1998; Li et al., 2001; Sakazume et al., 2007; Cottereau et al., 2013] . GPC4 duplication detected by MLPA has been reported in 2 individuals from one family with a clinical diagnosis of SGB syndrome [Cottereau et al., 2013] . It remains to be seen if GPC4 is important in SGB. Clinical diagnosis of SGB can be challenging. For example, Cottereau et al. [2013] described that over 90% of the samples referred to their laboratory with suspected SGB did not have GPC3 mutations.
Weaver Syndrome
Patients with Weaver syndrome (OMIM 277590), also known as EZH2 -related overgrowth, have some clinical overlap with features resembling Sotos syndrome includ- [Greer et al., 2008] . Tumor risks were highest in the IC1 (H19/IGF2:IG-DMR) hypermethylation subgroup (28%) and pUPD subgroup (16%) and were lower in the KCNQ1OT1:TSS-DMR (IC2) subgroup (2.6%), CDKN1C (6.9%) subgroup, and in clinically diagnosed patients in whom no molecular defect was detectable (6.7%) [Maas et al., 2016] .
Costello Approximately 15% lifetime risk of solid tumors including rhabdomyosarcoma, neuroblastoma, and transitional cell carcinoma of the bladder [Kratz et al., 2011] .
Gorlin 90% of patients develop jaw keratocysts, 90% develop basal cell carcinoma, 5% develop primitive neuroectodermal tumor, 20% of females develop ovarian fibroma, 2% develop cardiac fibromas. Lymphoma and meningioma have been reported [Cowan et al., 1997; Gorlin, 2004; Watson et al., 2004] .
PIK3CA-related overgrowth spectrum (PROS)
Further evidence of neoplasia risk is needed. There are case reports of leukemia, meningioma, retinoblastoma, and Wilms tumor. Benign vascular tumors are common [Gripp et al., 2016] .
NF1
Neurofibromas occur in the majority of patients. Plexiform neurofibromas occur in ~50%. Optic nerve gliomas in ~10 -15%. Brain tumors in ~1%. Malignant peripheral nerve sheath tumors occur in ~10% of patients. Women have a 3.5-fold increased risk of developing breast cancer overall. Other reported tumors include leukemia, pheochromocytoma, gastrointestinal stromal tumors, malignant melanoma, and glomus tumor [Sharif et al., 2007; Wang et al., 2012; Friedman, 2017] .
Perlman 64% risk of Wilms tumor in surviving children [Astuti et al., 2012] .
Proteus
The exact tumor risk is difficult to quantify. The most common tumors include monomorphic adenomas of the parotid glands, and bilateral ovarian cystadenomas. Other reported tumors include meningioma and ovarian tumors [Biesecker, 2006] .
PTEN hamartoma tumor syndrome
The lifetime risk of developing breast cancer is 25 -50%, The lifetime risk for thyroid cancer (usually follicular) is ~10%. The risk of endometrial cancer may approach 5 -10%. Other benign tumors include multiple types of skin lesion, hamartomatous intestinal polyps, fibrocystic disease of the breast, lipomas, fibromas, angiolipomas, hemangiomyolipomas, and brain tumors. Malignant tumors include renal cell carcinoma, melanoma, and colorectal cancer [Ngeow et al., 2011; Tan et al., 2012] .
RASA1-related disorders (Parkes-Weber) Revencu et al. [2008] reported that 7/101 (6.9%) RASA1 positive patients had tumors. Tumors included vestibular schwannoma, neurofibroma, non-small cell lung cancer, angiolipoma, lipoma, superficial basal cell carcinoma, optic glioma.
Schimmelpenning-Feuerstein-Mims Secondary tumors can often develop in an epidermal nevus (~24%). However, the exact tumor incidence in Schimmelpenning-Feuerstein-Mims syndrome is currently unknown [Groesser et al., 2012] .
Simpson-Golabi-Behmel Tumor frequency of perhaps 10% including Wilms tumor, hepatoblastoma, hepatocellular carcinoma, adrenal neuroblastoma, gonadoblastoma [Li et al., 2001; Lapunzina et al., 2005] . Recent data suggests the tumor frequency could be lower as 1/34 patients developed Wilms tumor and 1/34 patients developed leukemia [Cottereau et al., 2013] .
Sotos
The exact tumor risk remains controversial and is perhaps 3%. Reported tumors include sacrococcygeal teratoma, neuroblastoma, presacral ganglioma, ALL, retinoblastoma, and small cell lung cancer [TattonBrown et al., 2005 [TattonBrown et al., , 2017a Fickie et al., 2011 ].
Sotos-like syndrome (NFIX) 1/9 reported patients had a Wilms tumor. More information is required before attributing a neoplasia risk to NFIX mutations [Malan et al., 2010] .
Tatton-Brown-Rahman AML reported in one patient [Kosaki et al., 2017] .
Weaver Tumor frequency of perhaps 4% including neuroblastoma, acute lymphoblastic leukemia, ovarian endodermal sinus tumor, sacrococcygeal teratoma, and lymphoma Basel-Vanagaite, 2010; Gibson et al., 2012; Tatton-Brown and Rahman, 2013; . No specific protocol for cancer surveillance has yet been validated.
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BWS, Beckwith-Wiedemann syndrome. IC1/2, imprinting center 1/2.
Generalized Overgrowth Syndromes
Mol Syndromol 2018;9:70-82 DOI: 10.1159/000484532 75 ing pre-and postnatal overgrowth. Over 80% of reported patients have intellectual disability. Craniofacial features include a broad forehead and face, wide-spaced eyes, almond-shaped and downslanting palpebral fissures, prominent wide philtrum, retrognathia, and a deep horizontal chin groove. The latter often gives the chin a "stuck-on" appearance. The facial features can become less recognizable with age. Other findings can include scoliosis, large hands and feet, camptodactyly ( ∼ 45%), advanced bone age, deep-set nails, hypotonia (45%), hypertonia ( ∼ 30%), low-pitched cry ( ∼ 35%), umbilical hernia ( ∼ 45%), and soft doughy skin ( ∼ 50%). Neuronal migration defects can be seen as well as seizures. Embryonal and hematologic tumors may occur in up to 5% of the patients Basel-Vanagaite, 2010; Tatton-Brown et al., 2011; Gibson et al., 2012; Tatton-Brown and Rahman, 2013; , though no specific protocol for cancer surveillance has yet been validated.
EED-Associated Overgrowth and SUZ12-Associated Overgrowth
Patients with mutations in these genes have phenotypes resembling Weaver syndrome. Four patients have been reported with EED mutations and 1 patient with a SUZ12 mutation. The patients had overgrowth from birth, developmental delay/mild to moderate intellectual disability, and facial features resembling Weaver syndrome (round face, long philtrum, and retrognathia with "stuckon" chin). Other features reported include large ears, prominent crease between the lower lip and chin, scoliosis, osteopenia, large hands and feet with slender fingers and toes, flexion deformities of fingers, multiple nevi, cleft palate (1 patient), posterior ear pits (1 patient), inguinal and femoral herniae (1 patient), epilepsy (1 patient), and constipation (1 patient) [Cohen et al., 2015; Cohen and Gibson, 2016; Cooney et al., 2017; Imagawa et al., 2017] .
Tatton-Brown-Rahman Syndrome
Twenty patients with heterozygous DNMT3A mutations have been reported. Clinical features of TattonBrown-Rahman syndrome (OMIM 615879) include tall stature, macrocephaly, intellectual disability, characteristic facial features including a round face, heavy horizontal eyebrows, and narrow, small or downslanting palpebral fissures. A "marked philtrum with triangular interpillar space" has been described. Some patients had atrial septal defects, seizures, and scoliosis. Low tone and joint hypermobility are common findings [Tatton-Brown et al., 2014; Tlemsani et al., 2016] .
Bannayan-Riley-Ruvalcaba Syndrome
Bannayan-Riley-Ruvalcaba syndrome (OMIM 153480) is also known as PTEN -related disorders. Macrosomia at birth is commonly seen, but growth may slow down in childhood. However, significant macrocephaly persists throughout life. Enlarged penis, testicles, and macules on the glans penis are occasionally present. Facial and physical findings may include a prominent forehead, downslanting palpebral fissures, supernumerary nipples, joint hypermobility, and pectus excavatum. Intestinal hamartomatous polyposis and lipomas may be detected in childhood. The condition is allelic to Cowden syndrome, so later onset of benign and malignant tumors such as thyroid, breast, and endometrium may occur. Skin lesions such as trichilemmomas, acral keratoses, papillomatous lesions, and mucosal lesions can also occur [Marsh et al., 1997; Longy et al., 1998; Lachlan et al., 2007] .
Primrose Syndrome
Intellectual disability, enlarged and calcified external ears as well as distal muscle wasting are the main features of this condition. Microphthalmia, cataract, congenital heart disease, sparse body hair, diabetes, deafness, hypothyroidism, and corpus callosum hypoplasia can be seen. Primrose syndrome (OMIM 259050) is associated with progressive neurological deterioration with ataxia and/or pyramidal signs. Characteristic facial features include deeply set eyes, downslanting palpebral fissures, ptosis, and a high nasal bridge. MRI may show basal ganglia calcifications. The condition is caused by ZBTB20 mutations [Cordeddu et al., 2014; Mattioli et al., 2016] .
Sotos Syndrome 2
Patients with haploinsufficiency caused by whole gene deletions of NFIX or mutations within NFIX exhibit postnatal overgrowth that is sometimes also present prenatally. Reported patients with Sotos Syndrome 2 (OMIM 614753), also known as Sotos-like and Malan syndrome, have a long/narrow face, high forehead, downslanting palpebral fissures, small mouth, and an everted lower lip. Other findings include scoliosis, pectus excavatum, advanced bone age, slender body habitus, intellectual disability, hypotonia, and autistic traits. Since first reported in 2010, there have been 3 publications with 11 reported patients [Malan et al., 2010; Yoneda et al., 2012; Klaassens et al., 2015] .
Macrosomia, Obesity, Macrocephaly, and Ocular Abnormalities Syndrome
Only 8 cases have been reported in the literature. The syndrome consists of macrosomia, obesity, macrocephaly, ocular abnormalities (MOMO; OMIM 157980) including retinal or choroidal coloboma, microphthalmia, or optic atrophy, and mild to moderate intellectual impairment. A high forehead, up-or downslanting palpebral fissures, hypogenitalism, and seizures may also be seen. Four patients had normal height or short stature, and MOMO syndrome may be alternatively classified as an obesity syndrome or macrocephaly syndrome. The etiology is currently unknown [Di Donato et al., 2012; Vu et al., 2012] .
PPP2R5B, PPP2R5C, and PPP2R5D-Related Overgrowth
Five genes encode PP2A-B56 subunit proteins, PPP2R5A , PPP2R5B , PPP2R5C , PPP2R5D , and PPP2R5E. Exome sequencing in 363 patients with overgrowth detected 3 mutations in PPP2R5D , 1 mutation in PPP2R5B, and 1 mutation in PPP2R5C . All 5 patients exhibited overgrowth or tall stature with mild to moderate intellectual disability, although their facial features were not particularly distinct, and there was no consistent recognizable phenotype. Hypospadias and poor feeding, Parkinsonism, and facial asymmetry were each reported in only 1 patient, respectively [Loveday et al., 2015] . Eleven other patients with PP2R5D mutations have been reported and most did not have overgrowth, but 7 patients had macrocephaly. However, the other patients had normal head size or microcephaly [Houge et al., 2015] .
Susceptibility to Autism 18
From an autism cohort of 3,730 children, 15 individuals with mutations in CHD8 (Susceptibility to autism 18; OMIM 615032) were identified. Of these, 86% were tall, and 80% of individuals had macrocephaly. Physical findings included prominent supraorbital ridges, downslanting palpebral fissures, a broad nose with full nasal tip, pointed chin, tall slender build, and flat feet. Constipation, sleep disturbance, and seizures were reported in some patients [Bernier et al., 2014] .
Tenorio Syndrome
Six patients from 4 families were described with overgrowth present from birth. Some of the patients had hypoglycemia, hypotonia, and macroglossia at birth. Five out of 6 patients had mild to moderate intellectual disability. Slightly dilated ventricles were present on MRI.
Three out of 6 patients had autoimmune features such as Raynaud phenomenon and keratoconjunctivitis. A common facial phenotype was not reported aside from a broad forehead. Review of clinical photographs showed features such as thick eyebrows and a wide, upturned nose. The condition is caused by heterozygous mutations in RNF125 (Tenorio syndrome; OMIM 616260) [Tenorio et al., 2014] .
Macrocephaly, Dysmorphic Facies, and Psychomotor Retardation
Overgrowth and intellectual disability have been reported in 5 patients homozygous for HERC1 mutations (Macrocephaly, dysmorphic facies, and psychomotor retardation; OMIM 617011). Dysmorphic findings include a long face with a high forehead, up-or downslanting palpebral fissures, wide-spaced eyes, and sparse flared eyebrows. Joint laxity and hypotonia (5 patients) as well as kyphoscoliosis (3 patients) have been reported. Seizures were present in 2 patients. MRI may be normal or may demonstrate a thick corpus callosum, cerebellar hypoplasia, or ventriculomegaly [Ortega-Recalde et al., 2015; Aggarwal et al., 2016; Nguyen et al., 2016] .
Macrocephaly, Macrosomia, Facial Dysmorphism Syndrome
Only 6 patients have been reported with Macrocephaly, macrosomia, facial dysmorphism syndrome (OMIM 614192) in 2007, so caution may be required when ascribing pathogenicity to dominant mutations in RNF135 . Patients may have mild to moderate postnatal overgrowth, a broad forehead, downslanting palpebral fissures, broad nasal tip, long philtrum, thin upper lip, and a full lower lip. Intellectual disability may be mild to severe but RNF135 mutations can be inherited from an intellectually normal parent with only mild features of overgrowth [Douglas et al., 2007] . More research is required as RNF135 mutations may not be a common finding in patients with overgrowth [Visser et al., 2009] .
Rahman Syndrome (MIM # 617537)
A recent paper by Tatton-Brown et al. [2017b] performed exome sequencing on 710 individuals. Five patients had mutations in HIST1H1E. Clinical findings of Rahman syndrome (OMIM 617537) included mild to moderate intellectual disability, full cheeks, high hairline, and telecanthus. Overgrowth present early in life may not persist beyond early childhood.
X-Linked Mental Retardation 93
One percent of individuals in the overgrowth cohort presented by Tatton-Brown et al. [2017b] have a mutation in the X-linked BRWD3 gene. Clinical features of Xlinked mental retardation 93 (OMIM 300659) in previously reported families included macrocephaly, tall stature, a long face, pointed chin, and large, prominent ears [Field et al., 2007] .
Luscan-Lumish Syndrome
Only 4 patients with a SETD2 mutation have been reported in the medical literature, so caution is required when ascribing overgrowth to this gene. Luscan-Lumish syndrome (OMIM 616831) has been linked to mild to moderate intellectual disability and/or autism spectrum disorder, a prominent forehead with a high frontal hairline as well as long and large hands/feet [Luscan et al., 2014; Lumish et al., 2015; Tlemsani et al., 2016] .
Thauvin-Robinet-Faivre Syndrome
Four patients from 2 families have been reported with overgrowth and mild to severe intellectual disability. Other clinical findings reported include congenital heart disease (2 patients), retinal coloboma (2 patients), renal malformations (2 patients), chronic neutropenia (2 patients), cataract (1 patient), strabismus (1 patient), severe varicose veins (1 patient), sensorineural hearing loss (1 patient), and Wilms tumor (1 patient). Mild dysmorphic findings in some patients included downslanting palpebral fissures, epicanthic folds, flat midface and full/thick lips, large hands and feet, large thumbs, and spatulate digits. Thauvin-Robinet-Faivre syndrome (OMIM 617107) is autosomal recessive due to mutations in FIBP [Akawi et al., 2016; Thauvin-Robinet et al., 2016] .
Kosaki Overgrowth Syndrome
Four patients with gain-of-function mutations in PDGFRB have been reported. Patients with Kosaki overgrowth syndrome (OMIM616592) had a similar phenotype consisting of tall stature, long lower segment, long hands and feet, hyperelastic fragile skin, scoliosis, white matter lesions, and neurologic deterioration. Facial features included sparse hair, prominent forehead, proptosis, downslanting palpebral fissures, wide nasal bridge, thin upper lip, and a pointed chin. Lipodystrophy and premature aging appearance was also noted [Takenouchi et al., 2015; Minatogawa et al., 2017] . The head circumferences of the patients were not included in the research article, and this condition may be better classified as a genetic syndrome associated with tall stature and postnatal bony overgrowth. Further phenotypic reports will clarify this.
TCF20
Mutations TCF20 mutations have been implicated in autism spectrum disorder [Babbs et al., 2014] . Two patients have been reported with a postnatal overgrowth phenotype and a TCF20 de novo mutation. Clinical features included intellectual impairment and hypotonia. Minor dysmorphic or abnormal physical findings included a prominent forehead, downturned corners of the mouth, and inverted nipples. One patient had epilepsy, and one patient had an advanced bone age, mild scoliosis, and small penis [Schäfgen et al., 2016] .
Diagnostic Approach
Based on this review, we created a flow chart and provide examples of facial phenotypes to aid with the clinical diagnosis of overgrowth patients ( Fig. 1 ) . A glossary of "diagnostic handles" is also presented in Table 4 . When possible, chromosomal microarray and other molecular investigations should follow.
Discussion
The tables classifying overgrowth syndromes reveal a large number of conditions, and the underlying genetic mechanisms have been elucidated in the majority of these. Clinical acumen and accurate phenotyping should diagnose the more common syndromes such as BWS, Sotos, and Weaver syndrome. However, molecular genetic confirmation and molecular classification is important as the number of overgrowth syndromes is now large, and the phenotypes often overlap with patients exhibiting similar facial findings . Exome sequencing or gene panel design will therefore be the most useful investigation. This review provides an overgrowth syndrome gene list to prioritize variants examined at exome sequencing. The current list we suggest is:
, and ZBTB20.
In the era of massively parallel sequencing, accurate clinical diagnosis can limit the number of genes to be an- [Choufani et al., 2015] .
As molecular diagnoses increase, more phenotypic information will be gathered for the recently described syndromes to better inform management and prognosis of these diagnoses.
There are still gaps in diagnosis, and many overgrowth patients will remain undiagnosed even with exome sequencing. Tatton-Brown et al. [2017b] demonstrated a Cantu, Tatton-Brown-Rahman BWS, Beckwith-Wiedemann syndrome; CATSHL, camptodactyly, tall stature, scoliosis, and hearing loss syndrome; MCAP, megalencephaly-capillary malformation syndrome; MOMO, macrosomia, obesity, macrocephaly, and ocular abnormalities syndrome; MPPH, megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; SGB, Simpson-Golabi-Behmel syndrome.
Mol Syndromol 2018;9:70-82 DOI: 10.1159/000484532 80 50% detection rate in an overgrowth cohort of 710 individuals. However, 34% had NSD1 mutations; 4.8% had EZH2 mutations, and it could be argued that clinical diagnosis prior to exome sequencing was possible for most of these patients. The next order in frequency of mutation identification was DNMT3A (2.5%), PTEN (2.3%), NFIX (2.0%), CHD8 (1.7%), BRWD3 (1.0%), HIST1H1E (0.7%), PPP2R5D (0.4%), EED (0.3%), GPC3 (0.3%), and MTOR (0.3%) [Tatton-Brown et al., 2017b] .
More genes associated with an overgrowth phenotype may be discovered in the future, and this explains why some patients do not achieve a diagnosis even with accurate phenotyping and exome sequencing. We hypothesize that many patients with an apparent overgrowth phenotype have familial tall stature and a separate cause of intellectual disability. Also, the large stature seen in patients with intellectual disability may have polygenic causes.
Lastly, this review has enabled identification of some common molecular themes seen in some of the overgrowth syndromes. The presumed pathological basis behind overgrowth involves an increase in cell numbers, cell size, or both. The interplay between the multiple mechanisms involved in growth regulation remains incompletely understood at a molecular level, but classifying and studying overgrowth syndromes provides insight into the control of cellular growth and also tumor formation often observed in patients with overgrowth [Neylon et al., 2012; Tatton-Brown and Rahman, 2013; TattonBrown and Weksberg, 2013] . One of the most important mechanisms in overgrowth is perturbation of epigenetic regulation. The following genes are involved in histone modification, chromatin modeling, or DNA methylation: DNMT3A , EED , EZH2 , HIST1H1E , NSD1 , SETD2 , and SUZ12. The PI3K/AKT/mTOR pathway is also important [Imagawa et al., 2017; Tatton-Brown et al., 2017b] .
